A549 cells infected with RSV Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOXF2
|
ENSG00000137273.3 | forkhead box F2 |
FOXJ1
|
ENSG00000129654.7 | forkhead box J1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOXJ1 | hg19_v2_chr17_-_74137374_74137385 | -0.85 | 1.5e-01 | Click! |
FOXF2 | hg19_v2_chr6_+_1389989_1390069 | 0.84 | 1.6e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_+_136676707 | 1.43 |
ENST00000329582.4
|
IL20RB
|
interleukin 20 receptor beta |
chr8_-_131028782 | 1.37 |
ENST00000519020.1
|
FAM49B
|
family with sequence similarity 49, member B |
chr3_+_136676851 | 1.25 |
ENST00000309741.5
|
IL20RB
|
interleukin 20 receptor beta |
chr3_-_48956818 | 1.24 |
ENST00000408959.2
|
ARIH2OS
|
ariadne homolog 2 opposite strand |
chr2_+_175260514 | 1.19 |
ENST00000424069.1
ENST00000427038.1 |
SCRN3
|
secernin 3 |
chr4_-_140223614 | 1.04 |
ENST00000394223.1
|
NDUFC1
|
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa |
chr11_-_115375107 | 1.03 |
ENST00000545380.1
ENST00000452722.3 ENST00000537058.1 ENST00000536727.1 ENST00000542447.2 ENST00000331581.6 |
CADM1
|
cell adhesion molecule 1 |
chr4_-_140223670 | 1.00 |
ENST00000394228.1
ENST00000539387.1 |
NDUFC1
|
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa |
chr2_+_33661382 | 1.00 |
ENST00000402538.3
|
RASGRP3
|
RAS guanyl releasing protein 3 (calcium and DAG-regulated) |
chr10_-_14050522 | 1.00 |
ENST00000342409.2
|
FRMD4A
|
FERM domain containing 4A |
chr6_+_21666633 | 1.00 |
ENST00000606851.1
|
CASC15
|
cancer susceptibility candidate 15 (non-protein coding) |
chr2_+_58655461 | 0.97 |
ENST00000429095.1
ENST00000429664.1 ENST00000452840.1 |
AC007092.1
|
long intergenic non-protein coding RNA 1122 |
chr16_+_77233294 | 0.89 |
ENST00000378644.4
|
SYCE1L
|
synaptonemal complex central element protein 1-like |
chr2_+_12857043 | 0.86 |
ENST00000381465.2
|
TRIB2
|
tribbles pseudokinase 2 |
chr5_+_133859996 | 0.85 |
ENST00000512386.1
|
PHF15
|
jade family PHD finger 2 |
chr10_-_375422 | 0.82 |
ENST00000434695.2
|
DIP2C
|
DIP2 disco-interacting protein 2 homolog C (Drosophila) |
chr1_+_66796401 | 0.81 |
ENST00000528771.1
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific |
chr11_+_1151573 | 0.77 |
ENST00000534821.1
ENST00000356191.2 |
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming |
chr8_-_134309823 | 0.72 |
ENST00000414097.2
|
NDRG1
|
N-myc downstream regulated 1 |
chr2_-_233877912 | 0.72 |
ENST00000264051.3
|
NGEF
|
neuronal guanine nucleotide exchange factor |
chr10_+_111985837 | 0.71 |
ENST00000393134.1
|
MXI1
|
MAX interactor 1, dimerization protein |
chr8_-_134309335 | 0.71 |
ENST00000522890.1
ENST00000323851.7 ENST00000518176.1 ENST00000354944.5 ENST00000537882.1 ENST00000522476.1 ENST00000518066.1 ENST00000521544.1 ENST00000518480.1 ENST00000523892.1 |
NDRG1
|
N-myc downstream regulated 1 |
chr8_+_31496809 | 0.71 |
ENST00000518104.1
ENST00000519301.1 |
NRG1
|
neuregulin 1 |
chr5_-_142065612 | 0.68 |
ENST00000360966.5
ENST00000411960.1 |
FGF1
|
fibroblast growth factor 1 (acidic) |
chr17_-_6947225 | 0.67 |
ENST00000574600.1
ENST00000308009.1 ENST00000447225.1 |
SLC16A11
|
solute carrier family 16, member 11 |
chr5_-_150460539 | 0.64 |
ENST00000520931.1
ENST00000520695.1 ENST00000521591.1 ENST00000518977.1 |
TNIP1
|
TNFAIP3 interacting protein 1 |
chr19_+_18496957 | 0.63 |
ENST00000252809.3
|
GDF15
|
growth differentiation factor 15 |
chr11_-_67374177 | 0.62 |
ENST00000333139.3
|
C11orf72
|
chromosome 11 open reading frame 72 |
chr13_-_41240717 | 0.61 |
ENST00000379561.5
|
FOXO1
|
forkhead box O1 |
chr19_-_58609570 | 0.61 |
ENST00000600845.1
ENST00000240727.6 ENST00000600897.1 ENST00000421612.2 ENST00000601063.1 ENST00000601144.1 |
ZSCAN18
|
zinc finger and SCAN domain containing 18 |
chr20_-_43150601 | 0.59 |
ENST00000541235.1
ENST00000255175.1 ENST00000342374.4 |
SERINC3
|
serine incorporator 3 |
chr12_-_96389702 | 0.59 |
ENST00000552509.1
|
HAL
|
histidine ammonia-lyase |
chr8_-_116673894 | 0.57 |
ENST00000395713.2
|
TRPS1
|
trichorhinophalangeal syndrome I |
chr12_+_28605426 | 0.56 |
ENST00000542801.1
|
CCDC91
|
coiled-coil domain containing 91 |
chr9_-_4859260 | 0.55 |
ENST00000599351.1
|
AL158147.2
|
HCG2011465; Uncharacterized protein |
chr9_+_78505581 | 0.55 |
ENST00000376767.3
ENST00000376752.4 |
PCSK5
|
proprotein convertase subtilisin/kexin type 5 |
chr12_-_96390108 | 0.53 |
ENST00000538703.1
ENST00000261208.3 |
HAL
|
histidine ammonia-lyase |
chr5_-_150460914 | 0.51 |
ENST00000389378.2
|
TNIP1
|
TNFAIP3 interacting protein 1 |
chr17_+_9745786 | 0.51 |
ENST00000304773.5
|
GLP2R
|
glucagon-like peptide 2 receptor |
chr1_+_43855545 | 0.49 |
ENST00000372450.4
ENST00000310739.4 |
SZT2
|
seizure threshold 2 homolog (mouse) |
chr17_+_72426891 | 0.48 |
ENST00000392627.1
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
chr15_+_63188009 | 0.47 |
ENST00000557900.1
|
RP11-1069G10.2
|
RP11-1069G10.2 |
chr1_+_92545862 | 0.47 |
ENST00000370382.3
ENST00000342818.3 |
BTBD8
|
BTB (POZ) domain containing 8 |
chr8_+_11666649 | 0.47 |
ENST00000528643.1
ENST00000525777.1 |
FDFT1
|
farnesyl-diphosphate farnesyltransferase 1 |
chr1_+_25664408 | 0.46 |
ENST00000374358.4
|
TMEM50A
|
transmembrane protein 50A |
chr8_-_124553437 | 0.45 |
ENST00000517956.1
ENST00000443022.2 |
FBXO32
|
F-box protein 32 |
chr12_+_40787194 | 0.45 |
ENST00000425730.2
ENST00000454784.4 |
MUC19
|
mucin 19, oligomeric |
chr1_+_40862501 | 0.44 |
ENST00000539317.1
|
SMAP2
|
small ArfGAP2 |
chr6_+_12717892 | 0.44 |
ENST00000379350.1
|
PHACTR1
|
phosphatase and actin regulator 1 |
chr9_+_112852477 | 0.44 |
ENST00000480388.1
|
AKAP2
|
A kinase (PRKA) anchor protein 2 |
chr2_-_102091144 | 0.44 |
ENST00000428343.1
|
RFX8
|
RFX family member 8, lacking RFX DNA binding domain |
chr18_-_59415987 | 0.43 |
ENST00000590199.1
ENST00000590968.1 |
RP11-879F14.1
|
RP11-879F14.1 |
chr17_+_26662730 | 0.43 |
ENST00000226225.2
|
TNFAIP1
|
tumor necrosis factor, alpha-induced protein 1 (endothelial) |
chr19_+_50380917 | 0.41 |
ENST00000535102.2
|
TBC1D17
|
TBC1 domain family, member 17 |
chr12_-_58240470 | 0.41 |
ENST00000548823.1
ENST00000398073.2 |
CTDSP2
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 |
chr20_+_44420570 | 0.41 |
ENST00000372622.3
|
DNTTIP1
|
deoxynucleotidyltransferase, terminal, interacting protein 1 |
chr17_+_72427477 | 0.41 |
ENST00000342648.5
ENST00000481232.1 |
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
chr2_+_175260451 | 0.41 |
ENST00000458563.1
ENST00000409673.3 ENST00000272732.6 ENST00000435964.1 |
SCRN3
|
secernin 3 |
chr19_+_13906250 | 0.41 |
ENST00000254323.2
|
ZSWIM4
|
zinc finger, SWIM-type containing 4 |
chr12_-_116714564 | 0.41 |
ENST00000548743.1
|
MED13L
|
mediator complex subunit 13-like |
chr15_-_34610962 | 0.39 |
ENST00000290209.5
|
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6 |
chr16_+_777739 | 0.38 |
ENST00000563792.1
|
HAGHL
|
hydroxyacylglutathione hydrolase-like |
chr20_-_62582475 | 0.38 |
ENST00000369908.5
|
UCKL1
|
uridine-cytidine kinase 1-like 1 |
chr6_+_84563295 | 0.37 |
ENST00000369687.1
|
RIPPLY2
|
ripply transcriptional repressor 2 |
chr19_+_50380682 | 0.37 |
ENST00000221543.5
|
TBC1D17
|
TBC1 domain family, member 17 |
chr2_+_233527443 | 0.37 |
ENST00000410095.1
|
EFHD1
|
EF-hand domain family, member D1 |
chr2_-_165424973 | 0.37 |
ENST00000543549.1
|
GRB14
|
growth factor receptor-bound protein 14 |
chr19_+_7580103 | 0.36 |
ENST00000596712.1
|
ZNF358
|
zinc finger protein 358 |
chr2_-_37193606 | 0.36 |
ENST00000379213.2
ENST00000263918.4 |
STRN
|
striatin, calmodulin binding protein |
chr5_+_140529630 | 0.36 |
ENST00000543635.1
|
PCDHB6
|
protocadherin beta 6 |
chr6_-_25830785 | 0.36 |
ENST00000468082.1
|
SLC17A1
|
solute carrier family 17 (organic anion transporter), member 1 |
chr9_-_130679257 | 0.36 |
ENST00000361444.3
ENST00000335791.5 ENST00000343609.2 |
ST6GALNAC4
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 |
chr9_-_135819987 | 0.35 |
ENST00000298552.3
ENST00000403810.1 |
TSC1
|
tuberous sclerosis 1 |
chr17_+_67410832 | 0.35 |
ENST00000590474.1
|
MAP2K6
|
mitogen-activated protein kinase kinase 6 |
chr16_-_86542455 | 0.34 |
ENST00000595886.1
ENST00000597578.1 ENST00000593604.1 |
FENDRR
|
FOXF1 adjacent non-coding developmental regulatory RNA |
chr18_-_25739260 | 0.34 |
ENST00000413878.1
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal) |
chr19_+_18492973 | 0.34 |
ENST00000595973.2
|
GDF15
|
growth differentiation factor 15 |
chr7_+_134832808 | 0.34 |
ENST00000275767.3
|
TMEM140
|
transmembrane protein 140 |
chr1_+_43855560 | 0.33 |
ENST00000562955.1
|
SZT2
|
seizure threshold 2 homolog (mouse) |
chr8_-_133772794 | 0.33 |
ENST00000519187.1
ENST00000523829.1 ENST00000356838.3 ENST00000377901.4 ENST00000519304.1 |
TMEM71
|
transmembrane protein 71 |
chr2_-_39456673 | 0.33 |
ENST00000378803.1
ENST00000395035.3 |
CDKL4
|
cyclin-dependent kinase-like 4 |
chr1_+_65730385 | 0.33 |
ENST00000263441.7
ENST00000395325.3 |
DNAJC6
|
DnaJ (Hsp40) homolog, subfamily C, member 6 |
chr2_+_149402989 | 0.33 |
ENST00000397424.2
|
EPC2
|
enhancer of polycomb homolog 2 (Drosophila) |
chr14_-_36988882 | 0.32 |
ENST00000498187.2
|
NKX2-1
|
NK2 homeobox 1 |
chr3_-_71179988 | 0.31 |
ENST00000491238.1
|
FOXP1
|
forkhead box P1 |
chr4_+_71588372 | 0.31 |
ENST00000536664.1
|
RUFY3
|
RUN and FYVE domain containing 3 |
chr2_+_232575168 | 0.30 |
ENST00000440384.1
|
PTMA
|
prothymosin, alpha |
chr1_-_246357029 | 0.30 |
ENST00000391836.2
|
SMYD3
|
SET and MYND domain containing 3 |
chr10_+_70847852 | 0.30 |
ENST00000242465.3
|
SRGN
|
serglycin |
chr5_-_180076580 | 0.30 |
ENST00000502649.1
|
FLT4
|
fms-related tyrosine kinase 4 |
chr3_+_171561127 | 0.30 |
ENST00000334567.5
ENST00000450693.1 |
TMEM212
|
transmembrane protein 212 |
chr8_+_79428539 | 0.30 |
ENST00000352966.5
|
PKIA
|
protein kinase (cAMP-dependent, catalytic) inhibitor alpha |
chr1_-_6420737 | 0.29 |
ENST00000541130.1
ENST00000377845.3 |
ACOT7
|
acyl-CoA thioesterase 7 |
chr8_+_52730143 | 0.29 |
ENST00000415643.1
|
AC090186.1
|
Uncharacterized protein |
chr4_-_90756769 | 0.28 |
ENST00000345009.4
ENST00000505199.1 ENST00000502987.1 |
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr15_-_59041954 | 0.28 |
ENST00000439637.1
ENST00000558004.1 |
ADAM10
|
ADAM metallopeptidase domain 10 |
chr6_+_15401075 | 0.28 |
ENST00000541660.1
|
JARID2
|
jumonji, AT rich interactive domain 2 |
chr5_-_59064458 | 0.28 |
ENST00000502575.1
ENST00000507116.1 |
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
chr1_+_149239529 | 0.28 |
ENST00000457216.2
|
RP11-403I13.4
|
RP11-403I13.4 |
chr12_+_59989918 | 0.28 |
ENST00000547379.1
ENST00000549465.1 |
SLC16A7
|
solute carrier family 16 (monocarboxylate transporter), member 7 |
chr12_-_96390063 | 0.28 |
ENST00000541929.1
|
HAL
|
histidine ammonia-lyase |
chr4_+_117220016 | 0.28 |
ENST00000604093.1
|
MTRNR2L13
|
MT-RNR2-like 13 (pseudogene) |
chr15_+_74509530 | 0.27 |
ENST00000321288.5
|
CCDC33
|
coiled-coil domain containing 33 |
chr19_-_52531600 | 0.27 |
ENST00000356322.6
ENST00000270649.6 |
ZNF614
|
zinc finger protein 614 |
chr2_-_240230890 | 0.27 |
ENST00000446876.1
|
HDAC4
|
histone deacetylase 4 |
chr12_-_49504449 | 0.26 |
ENST00000547675.1
|
LMBR1L
|
limb development membrane protein 1-like |
chr11_+_32154200 | 0.26 |
ENST00000525133.1
|
RP1-65P5.5
|
RP1-65P5.5 |
chr3_+_98451532 | 0.26 |
ENST00000486334.2
ENST00000394162.1 |
ST3GAL6
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 6 |
chr11_-_85397167 | 0.26 |
ENST00000316398.3
|
CCDC89
|
coiled-coil domain containing 89 |
chr18_+_77160282 | 0.26 |
ENST00000318065.5
ENST00000545796.1 ENST00000592223.1 ENST00000329101.4 ENST00000586434.1 |
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr6_-_131321863 | 0.26 |
ENST00000528282.1
|
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
chr18_+_18943554 | 0.26 |
ENST00000580732.2
|
GREB1L
|
growth regulation by estrogen in breast cancer-like |
chr3_+_157828152 | 0.25 |
ENST00000476899.1
|
RSRC1
|
arginine/serine-rich coiled-coil 1 |
chr1_+_15668240 | 0.25 |
ENST00000444385.1
|
FHAD1
|
forkhead-associated (FHA) phosphopeptide binding domain 1 |
chr1_-_43855479 | 0.24 |
ENST00000290663.6
ENST00000372457.4 |
MED8
|
mediator complex subunit 8 |
chr4_+_166794383 | 0.24 |
ENST00000061240.2
ENST00000507499.1 |
TLL1
|
tolloid-like 1 |
chr11_-_119247004 | 0.24 |
ENST00000531070.1
|
USP2
|
ubiquitin specific peptidase 2 |
chr21_-_46293644 | 0.24 |
ENST00000330938.3
|
PTTG1IP
|
pituitary tumor-transforming 1 interacting protein |
chr3_-_185826855 | 0.23 |
ENST00000306376.5
|
ETV5
|
ets variant 5 |
chr2_+_179184955 | 0.23 |
ENST00000315022.2
|
OSBPL6
|
oxysterol binding protein-like 6 |
chr2_+_66918558 | 0.23 |
ENST00000435389.1
ENST00000428590.1 ENST00000412944.1 |
AC007392.3
|
AC007392.3 |
chr19_-_50380536 | 0.23 |
ENST00000391832.3
ENST00000391834.2 ENST00000344175.5 |
AKT1S1
|
AKT1 substrate 1 (proline-rich) |
chr7_-_25702669 | 0.22 |
ENST00000446840.1
|
AC003090.1
|
AC003090.1 |
chr1_+_150122034 | 0.22 |
ENST00000025469.6
ENST00000369124.4 |
PLEKHO1
|
pleckstrin homology domain containing, family O member 1 |
chr15_-_40600111 | 0.22 |
ENST00000543785.2
ENST00000260402.3 |
PLCB2
|
phospholipase C, beta 2 |
chr14_-_69262916 | 0.22 |
ENST00000553375.1
|
ZFP36L1
|
ZFP36 ring finger protein-like 1 |
chr15_-_76352069 | 0.22 |
ENST00000305435.10
ENST00000563910.1 |
NRG4
|
neuregulin 4 |
chr3_-_71632894 | 0.22 |
ENST00000493089.1
|
FOXP1
|
forkhead box P1 |
chr3_+_132316081 | 0.22 |
ENST00000249887.2
|
ACKR4
|
atypical chemokine receptor 4 |
chr11_-_34535297 | 0.22 |
ENST00000532417.1
|
ELF5
|
E74-like factor 5 (ets domain transcription factor) |
chr12_+_50135588 | 0.22 |
ENST00000423828.1
ENST00000550445.1 |
TMBIM6
|
transmembrane BAX inhibitor motif containing 6 |
chr15_-_34630234 | 0.21 |
ENST00000558667.1
ENST00000561120.1 ENST00000559236.1 ENST00000397702.2 |
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6 |
chr11_+_33061336 | 0.21 |
ENST00000602733.1
|
TCP11L1
|
t-complex 11, testis-specific-like 1 |
chr17_-_29641104 | 0.21 |
ENST00000577894.1
ENST00000330927.4 |
EVI2B
|
ecotropic viral integration site 2B |
chr6_+_32121908 | 0.21 |
ENST00000375143.2
ENST00000424499.1 |
PPT2
|
palmitoyl-protein thioesterase 2 |
chr11_-_5526834 | 0.21 |
ENST00000380237.1
ENST00000396895.1 ENST00000380252.1 |
HBE1
HBG2
|
hemoglobin, epsilon 1 hemoglobin, gamma G |
chr10_-_4285923 | 0.21 |
ENST00000418372.1
ENST00000608792.1 |
LINC00702
|
long intergenic non-protein coding RNA 702 |
chr19_-_49016847 | 0.21 |
ENST00000598924.1
|
CTC-273B12.10
|
CTC-273B12.10 |
chr3_-_157221128 | 0.20 |
ENST00000392833.2
ENST00000362010.2 |
VEPH1
|
ventricular zone expressed PH domain-containing 1 |
chr6_+_90192974 | 0.20 |
ENST00000520458.1
|
ANKRD6
|
ankyrin repeat domain 6 |
chr2_+_86947296 | 0.20 |
ENST00000283632.4
|
RMND5A
|
required for meiotic nuclear division 5 homolog A (S. cerevisiae) |
chr1_-_149982624 | 0.20 |
ENST00000417191.1
ENST00000369135.4 |
OTUD7B
|
OTU domain containing 7B |
chr10_+_75668916 | 0.20 |
ENST00000481390.1
|
PLAU
|
plasminogen activator, urokinase |
chr3_+_50712672 | 0.19 |
ENST00000266037.9
|
DOCK3
|
dedicator of cytokinesis 3 |
chr20_+_44035200 | 0.19 |
ENST00000372717.1
ENST00000360981.4 |
DBNDD2
|
dysbindin (dystrobrevin binding protein 1) domain containing 2 |
chr7_+_116593292 | 0.18 |
ENST00000393446.2
ENST00000265437.5 ENST00000393451.3 |
ST7
|
suppression of tumorigenicity 7 |
chr15_-_40600026 | 0.18 |
ENST00000456256.2
ENST00000557821.1 |
PLCB2
|
phospholipase C, beta 2 |
chr2_+_162272605 | 0.18 |
ENST00000389554.3
|
TBR1
|
T-box, brain, 1 |
chr12_+_50135327 | 0.17 |
ENST00000549966.1
ENST00000547832.1 ENST00000547187.1 ENST00000548894.1 ENST00000546914.1 ENST00000552699.1 ENST00000267115.5 |
TMBIM6
|
transmembrane BAX inhibitor motif containing 6 |
chr3_+_122513642 | 0.17 |
ENST00000261038.5
|
DIRC2
|
disrupted in renal carcinoma 2 |
chr4_-_90757364 | 0.17 |
ENST00000508895.1
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr15_-_59041768 | 0.17 |
ENST00000402627.1
ENST00000396140.2 ENST00000559053.1 ENST00000561288.1 |
ADAM10
|
ADAM metallopeptidase domain 10 |
chr3_-_164914640 | 0.17 |
ENST00000241274.3
|
SLITRK3
|
SLIT and NTRK-like family, member 3 |
chr20_+_45338126 | 0.17 |
ENST00000359271.2
|
SLC2A10
|
solute carrier family 2 (facilitated glucose transporter), member 10 |
chr5_-_180076613 | 0.16 |
ENST00000261937.6
ENST00000393347.3 |
FLT4
|
fms-related tyrosine kinase 4 |
chr6_-_161085291 | 0.16 |
ENST00000316300.5
|
LPA
|
lipoprotein, Lp(a) |
chr17_-_26662464 | 0.16 |
ENST00000579419.1
ENST00000585313.1 ENST00000395418.3 ENST00000578985.1 ENST00000577498.1 ENST00000585089.1 ENST00000357896.3 |
IFT20
|
intraflagellar transport 20 homolog (Chlamydomonas) |
chr18_-_53068782 | 0.16 |
ENST00000569012.1
|
TCF4
|
transcription factor 4 |
chr10_-_73848086 | 0.16 |
ENST00000536168.1
|
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
chr11_-_34535332 | 0.16 |
ENST00000257832.2
ENST00000429939.2 |
ELF5
|
E74-like factor 5 (ets domain transcription factor) |
chr20_+_44420617 | 0.16 |
ENST00000449078.1
ENST00000456939.1 |
DNTTIP1
|
deoxynucleotidyltransferase, terminal, interacting protein 1 |
chr1_+_185703513 | 0.15 |
ENST00000271588.4
ENST00000367492.2 |
HMCN1
|
hemicentin 1 |
chr1_-_43855444 | 0.15 |
ENST00000372455.4
|
MED8
|
mediator complex subunit 8 |
chr2_-_220264703 | 0.15 |
ENST00000519905.1
ENST00000523282.1 ENST00000434339.1 ENST00000457935.1 |
DNPEP
|
aspartyl aminopeptidase |
chr13_-_36920420 | 0.15 |
ENST00000438666.2
|
SPG20
|
spastic paraplegia 20 (Troyer syndrome) |
chr4_-_82393052 | 0.15 |
ENST00000335927.7
ENST00000504863.1 ENST00000264400.2 |
RASGEF1B
|
RasGEF domain family, member 1B |
chr4_-_186456766 | 0.15 |
ENST00000284771.6
|
PDLIM3
|
PDZ and LIM domain 3 |
chr12_+_72080253 | 0.15 |
ENST00000549735.1
|
TMEM19
|
transmembrane protein 19 |
chr16_-_84178728 | 0.15 |
ENST00000562224.1
ENST00000434463.3 ENST00000564998.1 ENST00000219439.4 |
HSDL1
|
hydroxysteroid dehydrogenase like 1 |
chr19_-_49016418 | 0.15 |
ENST00000270238.3
|
LMTK3
|
lemur tyrosine kinase 3 |
chr10_+_86184676 | 0.15 |
ENST00000543283.1
|
CCSER2
|
coiled-coil serine-rich protein 2 |
chr9_+_113431059 | 0.15 |
ENST00000416899.2
|
MUSK
|
muscle, skeletal, receptor tyrosine kinase |
chr5_-_131132658 | 0.14 |
ENST00000514667.1
ENST00000511848.1 ENST00000510461.1 |
CTC-432M15.3
FNIP1
|
Folliculin-interacting protein 1 folliculin interacting protein 1 |
chr17_+_22022437 | 0.14 |
ENST00000540040.1
|
MTRNR2L1
|
MT-RNR2-like 1 |
chr19_-_36523709 | 0.14 |
ENST00000592017.1
ENST00000360535.4 |
CLIP3
|
CAP-GLY domain containing linker protein 3 |
chr21_+_34602200 | 0.14 |
ENST00000382264.3
ENST00000382241.3 ENST00000404220.3 ENST00000342136.4 |
IFNAR2
|
interferon (alpha, beta and omega) receptor 2 |
chr18_-_53068940 | 0.14 |
ENST00000562638.1
|
TCF4
|
transcription factor 4 |
chr13_-_46756351 | 0.14 |
ENST00000323076.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
chr1_+_114473350 | 0.14 |
ENST00000503968.1
|
HIPK1
|
homeodomain interacting protein kinase 1 |
chr3_-_185826718 | 0.14 |
ENST00000413301.1
ENST00000421809.1 |
ETV5
|
ets variant 5 |
chr11_-_108464465 | 0.14 |
ENST00000525344.1
|
EXPH5
|
exophilin 5 |
chr17_-_29641084 | 0.14 |
ENST00000544462.1
|
EVI2B
|
ecotropic viral integration site 2B |
chr6_+_32121789 | 0.13 |
ENST00000437001.2
ENST00000375137.2 |
PPT2
|
palmitoyl-protein thioesterase 2 |
chr6_-_43027105 | 0.13 |
ENST00000230413.5
ENST00000487429.1 ENST00000489623.1 ENST00000468957.1 |
MRPL2
|
mitochondrial ribosomal protein L2 |
chr1_+_114472992 | 0.13 |
ENST00000514621.1
|
HIPK1
|
homeodomain interacting protein kinase 1 |
chr5_-_19988288 | 0.13 |
ENST00000502796.1
ENST00000511273.1 |
CDH18
|
cadherin 18, type 2 |
chr16_-_28374829 | 0.13 |
ENST00000532254.1
|
NPIPB6
|
nuclear pore complex interacting protein family, member B6 |
chr7_+_119913688 | 0.13 |
ENST00000331113.4
|
KCND2
|
potassium voltage-gated channel, Shal-related subfamily, member 2 |
chr12_-_21556577 | 0.13 |
ENST00000450590.1
ENST00000453443.1 |
SLCO1A2
|
solute carrier organic anion transporter family, member 1A2 |
chr10_+_115469134 | 0.13 |
ENST00000452490.2
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase |
chr1_-_28503693 | 0.12 |
ENST00000373857.3
|
PTAFR
|
platelet-activating factor receptor |
chrX_-_47863348 | 0.12 |
ENST00000376943.3
ENST00000396965.1 ENST00000305127.6 |
ZNF182
|
zinc finger protein 182 |
chr8_-_30002179 | 0.12 |
ENST00000320542.3
|
MBOAT4
|
membrane bound O-acyltransferase domain containing 4 |
chr11_-_16419067 | 0.12 |
ENST00000533411.1
|
SOX6
|
SRY (sex determining region Y)-box 6 |
chr16_+_28763108 | 0.11 |
ENST00000357796.3
ENST00000550983.1 |
NPIPB9
|
nuclear pore complex interacting protein family, member B9 |
chr6_+_22221010 | 0.11 |
ENST00000567753.1
|
RP11-524C21.2
|
RP11-524C21.2 |
chr19_+_41725140 | 0.11 |
ENST00000359092.3
|
AXL
|
AXL receptor tyrosine kinase |
chr18_-_53068911 | 0.11 |
ENST00000537856.3
|
TCF4
|
transcription factor 4 |
chr19_+_2270283 | 0.11 |
ENST00000588673.2
|
OAZ1
|
ornithine decarboxylase antizyme 1 |
chr14_+_23299088 | 0.11 |
ENST00000355151.5
ENST00000397496.3 ENST00000555345.1 ENST00000432849.3 ENST00000553711.1 ENST00000556465.1 ENST00000397505.2 ENST00000557221.1 ENST00000311892.6 ENST00000556840.1 ENST00000555536.1 |
MRPL52
|
mitochondrial ribosomal protein L52 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.7 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
0.3 | 0.9 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
0.2 | 1.1 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.2 | 1.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 1.4 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.1 | 0.8 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.1 | 0.6 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 1.4 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.1 | 0.8 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.6 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.1 | 0.3 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.1 | 0.5 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.1 | 0.5 | GO:0051620 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.1 | 0.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.5 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.1 | 0.8 | GO:0038129 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
0.1 | 0.7 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 1.1 | GO:1901898 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 0.5 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 0.6 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.4 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.3 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.1 | 0.4 | GO:0051029 | rRNA transport(GO:0051029) |
0.1 | 0.3 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.1 | 0.5 | GO:0031438 | negative regulation of mRNA cleavage(GO:0031438) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.1 | 0.7 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.4 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.0 | 0.2 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.0 | 0.3 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.0 | 0.4 | GO:0044211 | CTP salvage(GO:0044211) |
0.0 | 0.2 | GO:0097403 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
0.0 | 0.1 | GO:0071258 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.0 | 1.0 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.7 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 0.1 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.0 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.0 | 0.3 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.0 | 0.6 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.0 | 0.4 | GO:0021759 | globus pallidus development(GO:0021759) |
0.0 | 0.4 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.9 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.2 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.1 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.0 | 0.2 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.0 | 0.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.4 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.0 | 1.8 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.3 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.5 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.0 | 0.1 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) |
0.0 | 0.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.4 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 0.1 | GO:1903980 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) positive regulation of microglial cell activation(GO:1903980) |
0.0 | 0.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.0 | 0.0 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.0 | 0.3 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.0 | 0.4 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.1 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.0 | 0.6 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.1 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.0 | 0.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 | 1.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0015942 | formate metabolic process(GO:0015942) |
0.0 | 0.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.0 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
0.0 | 0.4 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.0 | 0.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.0 | GO:0008057 | eye pigment granule organization(GO:0008057) |
0.0 | 0.5 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.0 | 0.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.2 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.3 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.1 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.0 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.2 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.0 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.8 | GO:0070701 | mucus layer(GO:0070701) |
0.1 | 0.8 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.2 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.2 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.0 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 2.3 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.9 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.8 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 1.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.7 | GO:0016592 | mediator complex(GO:0016592) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.4 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
0.5 | 2.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 0.5 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
0.1 | 0.8 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.1 | 0.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.5 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.1 | 0.5 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.1 | 0.3 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.1 | 0.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.5 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.1 | 0.3 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.1 | 0.6 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 2.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 1.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.9 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.2 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.0 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.1 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.0 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.0 | 0.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 1.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.0 | 0.6 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 1.8 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.3 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.0 | 0.7 | GO:0044548 | fibroblast growth factor receptor binding(GO:0005104) S100 protein binding(GO:0044548) |
0.0 | 0.3 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.6 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.1 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.0 | 0.1 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.4 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.1 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.1 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.0 | 0.2 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.1 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) norepinephrine transmembrane transporter activity(GO:0005333) acetate ester transmembrane transporter activity(GO:1901375) |
0.0 | 0.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.1 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.0 | 1.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.0 | GO:0050692 | DBD domain binding(GO:0050692) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 1.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 1.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 1.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 1.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 1.0 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 1.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 1.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 1.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |